$HLGN
Heliogen Inc Stock $hlgn

$hlgn Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000184029223000021 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.394M	$1.937M	$3.539M
YoY Change	-41.72%	-45.27%	585.85%
Cost Of Revenue	$1.522M	$2.382M	$37.26M
YoY Change	-36.21%	-93.61%	7121.12%
Gross Profit	-$128.0K	-$445.0K	-$33.72M
YoY Change	-2233.33%	-98.68%
Gross Profit Margin	-9.18%	-22.97%	-952.87%
Selling, General & Admin	$17.65M	$4.165M	$20.40M
YoY Change	-21.86%	-79.58%	847.72%
% of Gross Profit
Research & Development	$4.946M	$5.260M	$9.605M
YoY Change	-19.54%	-45.24%	497.33%
% of Gross Profit
Depreciation & Amortization	$600.0K	$601.0K	$760.0K
YoY Change	-13.42%	-20.92%	1307.41%
% of Gross Profit
Operating Expenses	$22.60M	$10.43M	$30.00M
YoY Change	-21.36%	-65.22%	697.87%
Operating Profit	-$22.73M	-$10.88M	-$63.72M
YoY Change	-20.9%	-82.93%	1594.73%
Interest Expense	$270.0K	$283.0K	$194.0K
YoY Change	26.76%	45.88%	385.0%
% of Operating Profit
Other Income/Expense, Net	$827.0K	-$253.0K	-$76.00K
YoY Change	-858.72%	232.89%	130.3%
Pretax Income	-$21.68M	-$10.54M	-$59.58M
YoY Change	6.58%	-82.3%	1368.89%
Income Tax	$2.000K	$0.00	-$610.0K
% Of Pretax Income
Net Earnings	-$21.68M	-$10.54M	-$58.97M
YoY Change	7.25%	-82.12%	1353.85%
Net Earnings / Revenue	-1555.45%	-544.35%	-1666.23%
Basic Earnings Per Share	-$0.11	-$0.05	-$0.32
Diluted Earnings Per Share	-$0.11	-$0.05	-$0.32
COMMON SHARES
Basic Shares Outstanding	196.8M shares	195.8M shares	184.0M shares
Diluted Shares Outstanding	200.6M shares	196.9M shares	184.0M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.8M	$119.9M	$191.9M
YoY Change	-38.7%	-37.51%	10161.18%
Cash & Equivalents	$43.50M	$39.20M	$63.62M
Short-Term Investments	$64.31M	$80.70M	$128.3M
Other Short-Term Assets	$4.518M	$5.620M	$7.263M
YoY Change	-44.76%	-22.62%	1245.0%
Inventory	$4.304M	$2.900M
Prepaid Expenses
Receivables	$74.00K	$1.593M	$900.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$122.4M	$139.1M	$212.9M
YoY Change	-35.48%	-34.66%	8732.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.426M	$6.777M	$4.636M
YoY Change	-0.68%	46.18%
Goodwill	$0.00	$0.00	$1.111M
YoY Change	-100.0%	-100.0%
Intangibles			$4.063M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.006M	$8.104M	$16.06M
YoY Change	-74.62%	-49.55%
Total Long-Term Assets	$31.47M	$30.89M	$43.31M
YoY Change	-34.14%	-28.68%	-51.78%
TOTAL ASSETS
Total Short-Term Assets	$122.4M	$139.1M	$212.9M
Total Long-Term Assets	$31.47M	$30.89M	$43.31M
Total Assets	$153.9M	$170.0M	$256.2M
YoY Change	-35.21%	-33.65%	177.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$845.0K	$3.285M	$2.294M
YoY Change	-78.42%	43.2%
Accrued Expenses	$9.784M	$5.945M	$6.266M
YoY Change	68.86%	-5.12%	677.42%
Deferred Revenue	$12.25M	$10.97M	$7.900M
YoY Change	44.08%	38.81%	214.24%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$50.38M	$48.56M	$50.61M
YoY Change	2.49%	-4.07%	1196.8%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$31.00K
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$1.673M	$1.565M	$2.591M
YoY Change	-30.67%	-39.6%	-86.47%
Total Long-Term Liabilities	$1.673M	$1.565M	$2.622M
YoY Change	-31.41%	-40.31%	-86.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$50.38M	$48.56M	$50.61M
Total Long-Term Liabilities	$1.673M	$1.565M	$2.622M
Total Liabilities	$65.60M	$63.94M	$78.86M
YoY Change	-4.42%	-18.92%	293.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$340.8M	-$319.1M	-$225.5M
YoY Change	38.67%	41.49%	578.79%
Common Stock	$20.00K	$19.00K	$19.00K
YoY Change	5.26%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$88.32M	$106.0M	$177.3M
YoY Change
Total Liabilities & Shareholders Equity	$153.9M	$170.0M	$256.2M
YoY Change	-35.21%	-33.65%	177.75%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$21.68M	-$10.54M	-$58.97M
YoY Change	7.25%	-82.12%	1353.85%
Depreciation, Depletion And Amortization	$600.0K	$601.0K	$760.0K
YoY Change	-13.42%	-20.92%	1307.41%
Cash From Operating Activities	-$14.22M	-$24.13M	-$22.67M
YoY Change	63.75%	6.43%	3527.68%
INVESTING ACTIVITIES
Capital Expenditures	$327.0K	$527.0K	$1.360M
YoY Change	-115.4%	-61.25%	739.51%
Acquisitions
YoY Change
Other Investing Activities	$17.23M	$17.78M	-$101.4M
YoY Change	109.99%	-117.54%	266.82%
Cash From Investing Activities	$16.91M	$17.25M	-$102.7M
YoY Change	177.95%	-116.79%	269.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.075M	$248.0K	-$1.065M
YoY Change	58.55%	-123.29%	-101.46%
NET CHANGE
Cash From Operating Activities	-14.22M	-$24.13M	-$22.67M
Cash From Investing Activities	16.91M	$17.25M	-$102.7M
Cash From Financing Activities	1.075M	$248.0K	-$1.065M
Net Change In Cash	3.755M	-$6.631M	-$126.5M
YoY Change	-294.86%	-94.76%	-383.65%
FREE CASH FLOW
Cash From Operating Activities	-$14.22M	-$24.13M	-$22.67M
Capital Expenditures	$327.0K	$527.0K	$1.360M
Free Cash Flow	-$14.55M	-$24.66M	-$24.03M
YoY Change	121.73%	2.6%	2953.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001840292
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-40209
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Heliogen, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-4204953
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	130 West Union Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Pasadena
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91103
CY2023Q1	dei	City Area Code CityAreaCode	626
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	720-4530
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	196847953	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39215000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	45719000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	528000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	655000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	80700000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	97504000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	10646000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	9195000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	2900000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2442000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5092000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3306000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	139081000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	158821000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14373000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14772000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6777000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7071000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	135000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1160000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8104000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8295000	usd
CY2023Q1	us-gaap	Assets Assets	169970000	usd
CY2022Q4	us-gaap	Assets Assets	191619000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3285000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6921000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10966000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10348000	usd
CY2023Q1	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	28360000	usd
CY2022Q4	us-gaap	Provision For Loss On Contracts ProvisionForLossOnContracts	28418000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5945000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5602000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	48556000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	51289000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13483000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13921000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	338000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	642000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1565000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	443000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	63942000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	66295000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	195732947	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	195732947	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	50331	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	192924429	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	192924429	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	59770	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	425590000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	434478000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-457000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-593000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-319124000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-308580000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	106028000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125324000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	169970000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	191619000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	866000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2044000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1071000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1495000	usd
CY2023Q1	us-gaap	Revenues Revenues	1937000	usd
CY2022Q1	us-gaap	Revenues Revenues	3539000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	941000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2592000	usd
CY2023Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1071000	usd
CY2022Q1	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1495000	usd
CY2023Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	370000	usd
CY2022Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	33737000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2382000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	37824000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-445000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	-34285000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4165000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20062000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5260000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9375000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1008000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	10433000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	29437000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10878000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-63722000	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	283000	usd
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	194000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-304000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4026000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-253000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-76000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10544000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59578000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-610000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58968000	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	196899292	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	196899292	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	184031015	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	184031015	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58968000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	173000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-379000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-37000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	136000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-380000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	601000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	760000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10408000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-59348000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125324000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	136000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-9306000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	235000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	106028000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	214058000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58968000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-380000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12982000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	272000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	177303000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58968000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1008000	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	-9306000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12982000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-304000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4026000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1125000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	14000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-611000	usd
CY2023Q1	hlg	Non Cash Lease Expense NonCashLeaseExpense	400000	usd
CY2022Q1	hlg	Non Cash Lease Expense NonCashLeaseExpense	428000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	570000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-101000	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1497000	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	9693000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	458000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1786000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3802000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3084000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	456000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	705000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	6811000	usd
CY2023Q1	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	-77000	usd
CY2022Q1	hlg	Increase Decrease In Contract Loss Provisions IncreaseDecreaseInContractLossProvisions	33766000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	345000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	891000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24132000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22673000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	527000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1360000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	44520000	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	122468000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	62300000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	21100000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17253000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-102728000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	248000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	209000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2022Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1274000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	248000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1065000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6631000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-126466000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47874000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191581000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41243000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65115000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39215000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63615000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	528000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1500000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	41243000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65115000	usd
CY2023Q1	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	76000	usd
CY2022Q1	hlg	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	9339000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	56000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	19000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10500000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-142000000	usd
CY2023Q1	us-gaap	Investments And Cash InvestmentsAndCash	119900000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39200000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	80700000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and the accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to inputs used to recognize revenue over time, accounting for income taxes, fair values of share-based compensation, lease liabilities, warrant liabilities, contingent consideration, goodwill impairments and long-lived asset impairments. Despite our intention to establish accurate estimates and reasonable assumptions, actual results could differ materially from such estimates and assumptions.</span></div>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	866000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2044000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1071000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1495000	usd
CY2023Q1	us-gaap	Revenues Revenues	1937000	usd
CY2022Q1	us-gaap	Revenues Revenues	3539000	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1100000	usd
CY2022Q1	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	1500000	usd
CY2023Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	400000	usd
CY2023Q1	hlg	Loss On Contracts Amortization LossOnContractsAmortization	400000	usd
CY2022Q1	us-gaap	Contract With Customer Receivable Credit Loss Expense Reversal ContractWithCustomerReceivableCreditLossExpenseReversal	33700000	usd
CY2023Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	38500000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.21
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1593000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1119000	usd
CY2023Q1	us-gaap	Grants Receivable Current GrantsReceivableCurrent	8259000	usd
CY2022Q4	us-gaap	Grants Receivable Current GrantsReceivableCurrent	7188000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	529000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	560000	usd
CY2023Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	265000	usd
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	328000	usd
CY2023Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	10646000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	9195000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	560000	usd
CY2023Q1	hlg	Contract Assets Foreign Currency Translation Adjustments ContractAssetsForeignCurrencyTranslationAdjustments	12000	usd
CY2023Q1	hlg	Contract With Customer Asset Other Adjustment ContractWithCustomerAssetOtherAdjustment	-43000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	529000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10348000	usd
CY2023Q1	hlg	Contract With Customer Liability Increase For Deferred Revenue Additions ContractWithCustomerLiabilityIncreaseForDeferredRevenueAdditions	1464000	usd
CY2023Q1	hlg	Contract With Customer Liability Revenue Recognized Excluding Opening Balance ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance	774000	usd
CY2023Q1	hlg	Contract With Customer Liability Recognition Of Consideration Payable Excluding Opening Balance ContractWithCustomerLiabilityRecognitionOfConsiderationPayableExcludingOpeningBalance	76000	usd
CY2023Q1	hlg	Contract With Customer Liability Other Excluding Opening Balance ContractWithCustomerLiabilityOtherExcludingOpeningBalance	4000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10966000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent	80836000	usd
CY2023Q1	hlg	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Current DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent	136000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	80700000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLossCurrent	97813000	usd
CY2022Q4	hlg	Debt Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax Current DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent	309000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest Current DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	97504000	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Not Previously Recorded DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded	0	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest	0	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9933000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9648000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3156000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2577000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6777000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7071000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	600000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	300000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1000000.0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1004000	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-4000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1008000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	259000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	124000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	135000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4058000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3902000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	156000	usd
CY2022	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	400000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	21000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	532000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	811000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1309000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	729000	usd
CY2023Q1	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	1346000	usd
CY2022Q4	hlg	Accrued Research And Development Costs Current AccruedResearchAndDevelopmentCostsCurrent	1313000	usd
CY2023Q1	hlg	Inventory In Transit InventoryInTransit	0	usd
CY2022Q4	hlg	Inventory In Transit InventoryInTransit	654000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1608000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1570000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1150000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	525000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5945000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5602000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-10544000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58968000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	194650065	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	183949912	shares
CY2023Q1	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	2249227	shares
CY2022Q1	hlg	Weighted Average Number Of Shares Assumed Exercise Of Warrants WeightedAverageNumberOfSharesAssumedExerciseOfWarrants	81103	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	196899292	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	184031015	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	196899292	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	184031015	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-9199000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12982000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-9199000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12982000	usd

Files In Submission

Name	View Source	Status
0001840292-23-000021-index-headers.html	Edgar Link	pending
0001840292-23-000021-index.html	Edgar Link	pending
0001840292-23-000021.txt	Edgar Link	pending
0001840292-23-000021-xbrl.zip	Edgar Link	pending
ex311-2023q110xq.htm	Edgar Link	pending
ex312-2023q110xq.htm	Edgar Link	pending
ex321-2023q110xq.htm	Edgar Link	pending
ex322-2023q110xq.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hlg-20230331.htm	Edgar Link	pending
hlg-20230331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hlg-20230331_def.xml	Edgar Link	unprocessable
hlg-20230331_cal.xml	Edgar Link	unprocessable
hlg-20230331_lab.xml	Edgar Link	unprocessable
hlg-20230331_pre.xml	Edgar Link	unprocessable
hlg-20230331_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLGN
Heliogen Inc Stock $hlgn

2023 Q2 Form 10-Q Financial Statement

#000184029223000021 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN Heliogen Inc Stock $hlgn

2023 Q2 Form 10-Q Financial Statement

#000184029223000021 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLGN
Heliogen Inc Stock $hlgn